Recommended pre-submission checks
Powered by 

PAROLE RUBATE-RIVISTA INTERNAZIONALE DI STUDI SULLA CITAZIONE Journal Specifications
Indexed in the following public directories
Web of Science
DOAJ
| Overview | |
| Publisher | UNIV STUDI PARMA |
| Language | Spanish,Italian,French,English |
| Frequency | Semi-annual |
| Publication Time | 52 |
| Editorial Review Process | Double anonymous peer review |
| General Details | |
| Language | Spanish,Italian,French,English |
| Society/Institute/Sponsor | University of Parma |
| Frequency | Semi-annual |
| Publication Start Year | 2010 |
| Publisher URL | Visit website |
| Website URL | Visit website |
| Publication Details | |
| Plagiarism | Visit website |
| Publication Time | 52 |
| Editorial Review Detail | |
| Information for authors | |
| Author instructions | Visit website |
| Copyright Details | Visit website |
| License type | CC BY-NC |
| OA statement | Visit website |
View less
Planning to publish in PAROLE RUBATE-RIVISTA INTERNAZIONALE DI STUDI SULLA CITAZIONE ?
Upload your Manuscript to get
- Degree of match
- Common matching concepts
- Additional journal recommendations

Recently Published Papers in PAROLE RUBATE-RIVISTA INTERNAZIONALE DI STUDI SULLA CITAZIONE
Evaluation of functional autonomy and neuropsychiatric symptoms in dementia and Mild Cognitive Impairment: a retrospective observational protocol.
- 20 May 2026
- Neurodegenerative disease management
Plain language summary: the evoke(+) studies of semaglutide for early Alzheimer's disease.
- 20 May 2026
- Neurodegenerative disease management
Beyond chronological age: biological aging and its relevance for motor and cognitive function in multiple sclerosis.
- 19 May 2026
- Neurodegenerative disease management
Alzheimer's disease and apitherapy: the therapeutic effect of various honeybee products.
- 15 May 2026
- Neurodegenerative disease management
Which medication improves fatigue in patients with multiple sclerosis (MS)?: a systematic review and network meta-analysis.
- 14 May 2026
- Neurodegenerative disease management
Perspectives in dementia risk reduction - food for thought.
- 11 May 2026
- Neurodegenerative disease management
Evaluation of functional autonomy and neuropsychiatric symptoms in dementia and Mild Cognitive Impairment: a retrospective observational protocol.
- 20 May 2026
- Neurodegenerative disease management
Plain language summary: the evoke(+) studies of semaglutide for early Alzheimer's disease.
- 20 May 2026
- Neurodegenerative disease management
Beyond chronological age: biological aging and its relevance for motor and cognitive function in multiple sclerosis.
- 19 May 2026
- Neurodegenerative disease management
Alzheimer's disease and apitherapy: the therapeutic effect of various honeybee products.
- 15 May 2026
- Neurodegenerative disease management
Which medication improves fatigue in patients with multiple sclerosis (MS)?: a systematic review and network meta-analysis.
- 14 May 2026
- Neurodegenerative disease management
Perspectives in dementia risk reduction - food for thought.
- 11 May 2026
- Neurodegenerative disease management